Miltenyi Biotec Limited
Manufacture of basic pharmaceutical products · Woking
ActiveUnited KingdomIncorporated 1995Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 295 source facts · 32 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 295 source facts · 32 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 223
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.5
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2608_03096272_20251231
- Source archive
- Accounts_Monthly_Data-August2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-12-31
IXBRL · 296 source facts · 32 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 296 source facts · 32 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 224
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2507_03096272_20241231
- Source archive
- Accounts_Monthly_Data-July2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 309 source facts · 33 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 309 source facts · 33 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 238
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2476_03096272_20231231
- Source archive
- Accounts_Monthly_Data-September2024.zip
Registered details
03096272- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1995-08-30
- Jurisdiction
- —
- Registered office
- MILTENYI BIOTEC LTD, ALMAC HOUSE, WOKING, SURREY, GU24 9DR
Classification
2 SIC codes2110086900
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsMW-ATTC - RunwayInnovate UK · Centres · 2021-04-01 – 2022-03-31 · with 16 other participants£0awarded
MW-ATTC - Runway
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 16 other participants
£0
awarded
University Hospitals Birmingham NHS Foundation Trustlead£237,425
Velindre University NHS Trust£170,333
Nottingham University Hospitals NHS Trust£96,264
University Hospitals Bristol NHS Foundation Trust£67,412
University Hospitals of Leicester NHS Trust£67,412
Aston University£17,919
Miltenyi Biotec Limited£0
MW-ATTC - RunwayISCF · Centres · 2021-03-31 – 2022-03-30 · with 16 other participants£1,285,284whole project
MW-ATTC - Runway
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 16 other participants
£1,285,284
whole project
University Hospitals Birmingham NHS Foundation TrustleadAston UniversityBirmingham Women'S And Children'S Hospital CharityCellular Therapeutics LtdFourplus Immersive LtdGlobal Life Sciences Solutions Operations UK LtdIxaka LimitedMiltenyi Biotec LimitedNottingham University Hospitals NHS TrustOrbsen Therapeutics UK LtdThermo Electron LimitedTrakcel LimitedUniversity Hospitals Bristol NHS Foundation TrustUniversity Hospitals Of Leicester NHS TrustUniversity Of BirminghamVelindre University NHS TrustWorld Courier Management Limited
Northern Alliance Advanced Therapies Treatment CentreInnovate UK · Collaborative R&D · 2018-03-01 – 2022-03-31 · with 19 other participants£0awarded
Northern Alliance Advanced Therapies Treatment Centre
Innovate UK · Collaborative R&D · 2018-03-01 – 2022-03-31 · with 19 other participants
£0
awarded
The Newcastle upon Tyne Hospitals NHS Foundation Trustlead£1,623,506
Newcastle University£701,226
Scottish National Blood Transfusion Service£470,116
The Leeds Teaching Hospitals NHS Trust£459,749
Lothian Health Board£308,221
University of Edinburgh£276,428
NHS Blood and Transplant£261,849
NHS Greater Glasgow and Clyde£227,470
Miltenyi Biotec Limited£0
Northern Alliance Advanced Therapies Treatment CentreISCF · Collaborative R&D · 2018-03-01 – 2022-03-30 · with 19 other participants£7,544,329whole project
Northern Alliance Advanced Therapies Treatment Centre
ISCF · Collaborative R&D · 2018-03-01 – 2022-03-30 · with 19 other participants
£7,544,329
whole project
The Newcastle Upon Tyne Hospitals NHS Foundation TrustleadAlcyomics LimitedAsymptote LimitedAutolus LimitedCell Medica LimitedChiesi LimitedDatatrial LimitedHealth Innovation North East And North Cumbria LimitedLothian Health BoardMiltenyi Biotec LimitedNewcastle UniversityNHS Blood And TransplantNHS Greater Glasgow And ClydeRoslin Cell Therapies LimitedScottish National Blood Transfusion ServiceThe Leeds Teaching Hospitals NHS TrustThermo Electron LimitedTrakcel LimitedUniversity Of EdinburghWorld Courier Logistics (UK) Limited